Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/12/2017 12/13/2017 12/14/2017 12/15/2017 12/18/2017 Date
57.25(c) 58.51(c) 58.23(c) 57.04(c) 57.81 Last
1 214 589 1 206 664 1 435 168 1 506 449 400 827 Volume
-2.05% +2.20% -0.48% -2.04% +1.35% Change
More quotes
Financials ($)
Sales 2017 710 M
EBIT 2017 -49,3 M
Net income 2017 -51,3 M
Finance 2017 267 M
Yield 2017 -
Sales 2018 857 M
EBIT 2018 -16,8 M
Net income 2018 -30,5 M
Finance 2018 442 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 6,60x
EV / Sales2018 5,27x
Capitalization 4 957 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
Sector
Medical Equipment, Supplies & Distribution
Calendar
01/09 | 08:00pmPresentation
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
12/12 DEXCOM : Announces Upcoming Conference Presentation
11/30 DEXCOM : Raising funds for diabetes charities through social media
11/30 DEXCOM : Announces Development Agreement with Lilly to Integrate Dexcom CGM into..
11/27 DEXCOM : Announces Upcoming Conference Presentation
11/14 WORLD DIABETES DAY : More than 30 million people in the U.S. have diabetes
11/09 DEXCOM : Launches "Call of the Warrior" Campaign for National Diabetes Awareness..
11/09 THURSDAY 11/9 INSIDER BUYING REPORT : Dxcm, tep
11/09 DEXCOM : Announces Upcoming Conference Presentation
11/02 DEXCOM : Launches "Call of the Warrior" Campaign for National Diabetes Awareness..
11/02 DEXCOM : Launches “Call of the Warrior” Campaign for National Diabet..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
12/16 ESSILOR INTERNATIONAL : Luxottica CEO exits eyewear giant ahead of Essilor merge..
12/14 EXCLUSIVE : Luxottica, Essilor tie-up on track for unconditional EU okay - sourc..
12/11DJESSILOR INTERNATIONAL : Luxottica Group Will Have New CEO, Says Chief -FT
12/08 Toshiba, Western Digital aiming to settle chip dispute next week - sources
12/08 TOSHIBA, WESTERN DIGITAL AIMING TO S : sources
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
11/29 DexCom up 4% on potential CGM opportunity with UnitedHealth
11/21 DexCom teams up with Lilly to combine CGM into insulin lineup
11/17 Thursday Was About Wal-Mart And Cisco - Cramer's Mad Money (11/16/17)
11/01 DexCom (DXCM) Q3 2017 Results - Earnings Call Transcript
11/01 DexCom beats by $0.12, beats on revenue
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 67,7 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.-4.46%4 957
MEDTRONIC PLC17.23%113 017
BAXTER INTERNATIONAL47.34%35 594
C R BARD INC48.89%24 382
ZIMMER BIOMET HOLDINGS INC11.67%23 333
HOYA CORPORATION12.50%18 958